OpZira, Inc.
About OpZira, Inc.
OpZira, Inc. is an ophthalmic medical device company focused on technologies for early detection and comprehensive monitoring of ocular disease. The company develops AI-powered solutions including the AdaptDx Pro, a wearable dark adaptometer for eye disease diagnostics, as a spinout from Alcon's LumiThera. Its mission is to help clinicians detect ocular diseases earlier and monitor them more effectively to preserve vision and improve patient quality of life. Headquarters are at 1000 Kreider Drive, Suite 700, Middletown, Pennsylvania 17057.
Investors
Not disclosed in the source filing. Form D filings do not list investors — StreetZero surfaces them from news where available.
Key highlights
- Raised ~$1.1M Seed for AI-powered eye disease diagnostics
- Spinout from Alcon's LumiThera developing AdaptDx Pro wearable
- Headquartered in Middletown, PA
- Focus on early ocular disease detection and monitoring
Ask StreetZero about OpZira, Inc.
Put our AI to work on this deal.
Similar companies
Other Other Technology deals, ranked by Signal.
Source document & SEC filing
The source SEC filing and the cached document are available to members only. Sign in to view and download them.
Sign in to view the filing Create free account